Name: 25% Donald Trump tariff likely to weigh on pharma margins: Analysts
Uploaded: Tue, 12 Aug 2025 12:47:46 +0530
Channel: Rediff Video Desk
Description: If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts.This is after assuming that about 75 per cent of the tariff would be passed on.

Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.

Uploaded by: Rediff Video Desk on Tue, 12 Aug 2025 12:47:46 +0530

Views: 4

Tags: 25% Donald Trump tariff likely to weigh on pharma margins: Analysts